Format

Send to

Choose Destination
Semin Cutan Med Surg. 2016 Jun;35(2):50-6. doi: 10.12788/j.sder.2016.024.

Topical retinoids for acne.

Author information

1
Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
2
Pediatric Dermatology, Mount Sinai Health System, New York, New York, USA. nsilverb@chpnet.org.

Abstract

Topical retinoids are currently approved by the US Food and Drug Administration for the treatment of acne vulgaris in nonpregnant, nonlactating patients 12 years of age and older. Their efficacy, safety, and tolerability are well documented for inflammatory and noninflammatory acne with studies repeatedly demonstrating a decrease in the number of lesions, significant improvement in acne severity, improvement in the cosmetic appearance of acne, and the prevention of acne lesions through microcomedone formation. There is some variability between prescription retinoid products regarding efficacy, safety, and tolerability; with erythema, peeling, and dryness being common, potential side effects. Due to their efficacious and safe profile, topical retinoids remain the first-line treatment for acne vulgaris.

PMID:
27416308
DOI:
10.12788/j.sder.2016.024
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Frontline Medical Communications Inc
Loading ...
Support Center